Fabio Cp Navarro

11PUBLICATIONS
180CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Dec 16, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.

Elena Garralda, Charles Abbott, Alma Calahorro

|Jan 13, 2025
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.

James R M Black, Gabor Bartha, Charles W Abbott

|Aug 03, 2021
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms.

Charles W Abbott, Sean M Boyle, Rachel Marty Pyke

|May 28, 2021
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma.

Michael J Koenig, Bernice A Agana, Jacob M Kaufman

|Feb 07, 2020
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition.

Bernardo Rodriguez-Martin, Eva G Alvarez, Adrian Baez-Ortega

Pageof 2

Frequent Collaborators

3 joint publications

Mark Gerstein

3 joint publications

Richard O Chen

3 joint publications

Jan O Korbel

3 joint publications

Ken Chen